Cargando…

Anti-IL6R role in treatment of COVID-19-related ARDS

Detalles Bibliográficos
Autores principales:	Buonaguro, Franco Maria, Puzanov, Igor, Ascierto, Paolo Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7154570/ https://www.ncbi.nlm.nih.gov/pubmed/32290847 http://dx.doi.org/10.1186/s12967-020-02333-9

Ejemplares similares

Editorial: Advancements in Molecular Diagnosis and Treatment of Melanoma
por: Palmieri, Giuseppe, et al.
Publicado: (2021)

LK or IGF1R: When selectivity hurts
por: Puzanov, Igor, et al.
Publicado: (2015)

Potential Role of Anti-Complement Agents in the Treatment of COVID-19-Related ARDS
por: Spanopoulou, Christina, et al.
Publicado: (2020)

IL-6 modulation for COVID-19: the right patients at the right time?
por: Ascierto, Paolo Antonio, et al.
Publicado: (2021)

COVID-19 pneumonia: ARDS or not?
por: Gattinoni, Luciano, et al.
Publicado: (2020)

Caring for patients at risk of ARDS: the role of driving pressure
por: Plens, Glauco Cabral Marinho, et al.
Publicado: (2021)

Prone positioning in COVID-19 ARDS: more pros than cons
por: Battaglini, Denise, et al.
Publicado: (2022)

Lung targeted liposomes for treating ARDS
por: Arber Raviv, Sivan, et al.
Publicado: (2022)

Ventilatory Management of COVID-19-related ARDS: Stick to Basics and Infection Control
por: Chawla, Rajesh, et al.
Publicado: (2020)

Fibrinolytics as an ARDS Salvage Option: Promising, But ARDS Prevention Options Are Needed Urgently
por: Cap, Andrew P.
Publicado: (2022)

Melanoma: the role of surgery in the era of new therapies
por: Mozzillo, Nicola, et al.
Publicado: (2014)

Changes in TNF-α, IL-6, IL-10 and VEGF in rats with ARDS and the effects of dexamethasone
por: Qin, Mengting, et al.
Publicado: (2019)

Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19
por: Parums, Dinah V.
Publicado: (2021)

Perspectives on COVID-19 and cancer immunotherapy: a review series
por: Goldman, Jason D, et al.
Publicado: (2021)

Knowledge-based repositioning of the anti-HCV direct antiviral agent Sofosbuvir as SARS-CoV-2 treatment
por: Buonaguro, Luigi, et al.
Publicado: (2020)

Rapid and Impressive Response to a Combined Treatment with Single-Dose Tocilizumab and NIV in a Patient with COVID-19 Pneumonia/ARDS
por: Cascella, Marco, et al.
Publicado: (2020)

Gene expression in active systemic JIA after anti-IL1 and anti-IL6R treatment
por: Ogilvie, EM, et al.
Publicado: (2008)

Tumor biobanks in translational medicine
por: Botti, Gerardo, et al.
Publicado: (2012)

What is changing in the adjuvant treatment of melanoma?
por: Ascierto, Paolo A., et al.
Publicado: (2017)

How severe COVID-19 infection is changing ARDS management
por: Ferguson, Niall D., et al.
Publicado: (2020)

Secukinumab: The Anti-IL-17A Biologic for the Treatment of Psoriasis
por: Fargnoli, Maria Concetta
Publicado: (2019)

ECMO, ARDS and AH1N1
por: Zangrillo, A
Publicado: (2009)

TRALI or ARDS or TDGE versus blood transfusion
por: Rocha, Bruno da Costa
Publicado: (2015)

IL-6 serum level, ARDS, and AKI as risk factors for the COVID-19 infection’s mortality in children
por: Ganda, Idham Jaya, et al.
Publicado: (2023)

Why and how do we need comprehensive international clinical epidemiology of ARDS?
por: Tognoni, Gianni, et al.
Publicado: (2021)

Infections and cancer: debate about using vaccines as a cancer control tool
por: Mbulaiteye, Sam M, et al.
Publicado: (2013)

Human Papillomavirus and Cancers
por: Tornesello, Maria Lina, et al.
Publicado: (2020)

ARDS RELATED TO COVID-19
por: Sekhon, Jasmine, et al.
Publicado: (2020)

Special issue on Interleukin-6 (IL-6)
por: Rincon, Mercedes
Publicado: (2012)

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19
por: Ascierto, Paolo Antonio, et al.
Publicado: (2020)

Pediatric ARDS biomarkers: missing the random forest for the trees
por: Yehya, Nadir
Publicado: (2019)

We’ve never seen a patient with ARDS!
por: Vincent, Jean-Louis, et al.
Publicado: (2020)

Slicing and dicing ARDS: we almost forgot the lungs
por: Smit, Marry R., et al.
Publicado: (2021)

Melanoma: From Research to Treatment
por: Ascierto, Paolo A., et al.
Publicado: (2011)

Association of Polymorphisms of IL-6 Pathway Genes (IL6, IL6R and IL6ST) with COVID-19 Severity in an Amazonian Population
por: Rodrigues, Fabíola Brasil Barbosa, et al.
Publicado: (2023)

COVID-19 ARDS: Can Systemic Oxygenation Utilization Guide Oxygen Therapy?
por: Srinivasan, Shrikanth, et al.
Publicado: (2021)

Targeting IFNGR/IL6R or downstream JAK1/JAK2 to control GvHD
por: Ashami, Kidist, et al.
Publicado: (2018)

KL-6 in ARDS and COVID-19 Patients
por: Piazza, Ornella, et al.
Publicado: (2022)

High Induction of IL-6 Secretion From hUCMSCs Optimize the Potential of hUCMSCs and TCZ as Therapy for COVID-19-Related ARDS
por: Lo, Huei-Yu, et al.
Publicado: (2021)

The Role of Circulating Free DNA and MicroRNA in Non-Invasive Diagnosis of HBV- and HCV-Related Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_87j0clf3nf79sn3jl2qg8vicbl